Detailed View
LEU - Centrus Energy Corp.
Latest filing: 2026-03-31 | Reporting: gaap
1Y Price Chart
Company Summary
Centrus Energy Corp. supplies low-enriched uranium (LEU) fuel for nuclear power plants, with its American Centrifuge Plant in Piketon, Ohio producing HALEU (high-assay low-enriched uranium) for next-generation reactors. The business model combines long-term supply contracts with U.S. and international commercial utilities plus government contracts with the U.S. Department of Energy for HALEU production. Annual revenue is approximately $300-400M, with operations and customers primarily in North America. The company also provides technical and operational services to nuclear fuel cycle facilities under government cost-plus and fixed-price contracts.
Past Year Trends
- Centrus reported FY2024 total revenue of $442.0 million, up approximately 38% year-over-year from $320.2 million in FY2023, with uranium revenue specifically rising 70% driven by a 50% increase in average realized price and 13% higher volume sold. (Bullish)
- Net income declined from $84.4 million in FY2023 to $73.2 million in FY2024 despite the revenue surge, as cost of sales in the LEU segment rose from $163.9 million to $256 million, compressing gross margins and signaling rising production-cost pressure at the Piketon facility. (Bearish)
- In October 2024, the Department of Energy selected Centrus for both the HALEU Deconversion Contract (max aggregate $0.8 billion across all awardees) and the HALEU Production Contract expansion (max aggregate $2.7 billion across all awardees), materially expanding the company's government contract pipeline beyond its existing $3.7 billion backlog as of December 31, 2024. (Bullish)
Next Year Trends
- Centrus is in active negotiation with the DOE on a ~$900 million award to expand its Piketon, Ohio enrichment facility toward a 12-metric-ton-per-year HALEU production capacity; final contract execution and the pace of construction hiring (targeting 1,000 construction jobs and 300 permanent operating roles) represent the primary near-term binary catalyst for the stock. (Bullish)
- The Phase III HALEU Operation Contract, valued at approximately $110 million and running through June 30, 2026, expires within the next 12 months, and DOE holds discretionary options for up to eight additional annual extensions subject to congressional appropriations — making the FY2027 budget cycle and any continuing-resolution risk a direct headwind to revenue continuity. (Bearish)
- The National Nuclear Security Administration notified Centrus of intent to sole-source certain uranium enrichment activities to the company as the only production-ready domestic option for national security missions; finalization of that sole-source contract in the next 12 months would add a distinct, non-competitive revenue stream on top of the existing commercial LEU backlog of approximately $3.0 billion. (Bullish)
Red Flags
No severe red flags identified as of May 2026.
Updated 2026-05-20
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 76,700,000 | 800,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 146,200,000 | 12,800,000 |
| 2025-09-30 | 10-Q | 2025 | 74,900,000 | -16,600,000 |
| 2025-06-30 | 10-Q | 2025 | 154,500,000 | 33,500,000 |
| 2025-03-31 | 10-Q | 2025 | 73,100,000 | 20,500,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 151,600,000 | 45,100,000 |
| 2024-09-30 | 10-Q | 2024 | 57,700,000 | -7,600,000 |
| 2024-06-30 | 10-Q | 2024 | 189,000,000 | 21,100,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.